{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:18:00Z","timestamp":1792120680362,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41440-019-0339-y","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T08:03:31Z","timestamp":1570176211000},"page":"500-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy"],"prefix":"10.1038","volume":"43","author":[{"given":"Mirko","family":"Parasiliti-Caprino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Lucatello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Burrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Maletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinella","family":"Mistrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Migliore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"La Grotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Reimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giraudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Piovesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovannino","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e8sir\u00e8e","family":"Deandreis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Limone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Borretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Volante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Aimaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Terzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Morino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Arvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Maccario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"339_CR1","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh Q-Y, Eisenhofer G, Gimenez-Roqueplo A-P, Grebe SKG, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99:1915\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"339_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41440-017-0002-4","volume":"41","author":"Y Ohno","year":"2018","unstructured":"Ohno Y, Sone M, Taura D, Yamasaki T, Kojima K, Honda-Kohmo K. et al. Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors. Hypertens Res. 2018;41:165\u201375.","journal-title":"Hypertens Res"},{"key":"339_CR3","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1056\/NEJM198411153112007","volume":"311","author":"EL Bravo","year":"1984","unstructured":"Bravo EL, Gifford RW. Pheochromocytoma: diagnosis, localization and management. N Engl J Med. 1984;311:1298\u2013303.","journal-title":"N Engl J Med"},{"key":"339_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","volume":"26","author":"LDR Thompson","year":"2002","unstructured":"Thompson LDR. Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002;26:551\u201366.","journal-title":"Am J Surg Pathol"},{"key":"339_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/ERC-13-0494","volume":"21","author":"N Kimura","year":"2014","unstructured":"Kimura N, Takayanagi R, Takizawa N, Itagaki E, Katabami T, Kakoi N, et al. Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma. Endocr Relat Cancer. 2014;21:405\u201314.","journal-title":"Endocr Relat Cancer"},{"key":"339_CR6","first-page":"1","volume":"12","author":"JM Koh","year":"2017","unstructured":"Koh JM, Ahn SH, Kim H, Kim BJ, Sung TY, Kim YH, et al. Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma. PLoS ONE. 2017;12:1\u201314.","journal-title":"PLoS ONE"},{"key":"339_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-16-0033","volume":"174","author":"PF Plouin","year":"2016","unstructured":"Plouin PF, Amar L, Dekkers OM, Fassnach M, Gimenez-Roqueplo AP, Lenders JWM, et al. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016;174:1\u201310.","journal-title":"Eur J Endocrinol"},{"key":"339_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PLM Dahia","year":"2014","unstructured":"Dahia PLM. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer. 2014;14:108\u201319.","journal-title":"Nat Rev Cancer"},{"key":"339_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1530\/EJE-16-0189","volume":"175","author":"L Amar","year":"2016","unstructured":"Amar L, Lussey-Lepoutre C, Lenders JWM, Djadi-Prat J, Plouin PF, Steichen O. Recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis. Eur J Endocrinol. 2016;175:135\u201345.","journal-title":"Eur J Endocrinol"},{"key":"339_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12022-017-9484-5","volume":"28","author":"AK Lam","year":"2017","unstructured":"Lam AK. Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr Pathol. 2017;28:213\u201327.","journal-title":"Endocr Pathol"},{"key":"339_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12020-011-9545-3","volume":"40","author":"TIM Korevaar","year":"2011","unstructured":"Korevaar TIM, Grossman AB. Pheochromocytomas and paragangliomas: assessment of malignant potential. Endocrine. 2011;40:354\u201365.","journal-title":"Endocrine"},{"key":"339_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011;96:717\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"339_CR13","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1210\/jc.2004-2025","volume":"90","author":"G Eisenhofer","year":"2005","unstructured":"Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, et al. Biochemical and clinical manifestations of dopamine-producing paragangliomas: Utility of plasma methoxytyramine. J Clin Endocrinol Metab. 2005;90:2068\u201375.","journal-title":"J Clin Endocrinol Metab"},{"key":"339_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","volume":"57","author":"G Eisenhofer","year":"2011","unstructured":"Eisenhofer G, Lenders JWM, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem. 2011;57:411\u201320.","journal-title":"Clin Chem"},{"key":"339_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12022-011-9188-1","volume":"23","author":"G Eisenhofer","year":"2012","unstructured":"Eisenhofer G, Tischler AS, De Krijger RR. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification. Endocr Pathol. 2012;23:4\u201314.","journal-title":"Endocr Pathol"},{"key":"339_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1530\/EJE-17-0077","volume":"177","author":"D Rao","year":"2017","unstructured":"Rao D, Peitzsch M, Prejbisz A, Hanus K, Fassnacht M, Beuschlein F, et al. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma. Eur J Endocrinol. 2017;177:103\u201313.","journal-title":"Eur J Endocrinol"},{"key":"339_CR17","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","volume":"48","author":"G Eisenhofer","year":"2012","unstructured":"Eisenhofer G, Lenders JWM, Siegert G, Bornstein SR, Friberg P, Milosevic D, et al. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer. 2012;48:1739\u201349.","journal-title":"Eur J Cancer"},{"key":"339_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/01.HYP.36.6.1045","volume":"36","author":"F Rao","year":"2000","unstructured":"Rao F, Keiser HR, O\u2019Connor DT. Malignant pheochromocytoma: chromaffin granule transmitters and response to treatment. Hypertension. 2000;36:1045\u201352.","journal-title":"Hypertension"},{"key":"339_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/030089160509100110","volume":"91","author":"D Cotesta","year":"2005","unstructured":"Cotesta D, Caliumi C, Al\u00f2 P, Petramala L, Reale MG, Masciangelo R, et al. High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma. Tumori. 2005;91:53\u20138.","journal-title":"Tumori"},{"key":"339_CR20","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1210\/jc.2004-1398","volume":"90","author":"L Amar","year":"2005","unstructured":"Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab. 2005;90:2110\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"339_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4111\/kju.2011.52.4.241","volume":"52","author":"J Park","year":"2011","unstructured":"Park J, Song C, Park M, Yoo S, Park SJ, Hong S. et al. Predictive characteristics of malignant pheochromocytoma. Korean J Urol. 2011;52:241\u20136.","journal-title":"Korean J Urol"},{"key":"339_CR22","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.surg.2014.08.044","volume":"156","author":"D Press","year":"2014","unstructured":"Press D, Akyuz M, Dural C, Aliyev S, Monteiro R, Mino J, et al. Predictors of recurrence in pheochromocytoma. Surgery. 2014;156:1523\u20137.","journal-title":"Surgery"},{"key":"339_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0090-4295(98)00612-8","volume":"53","author":"H John","year":"1999","unstructured":"John H, Ziegler WH, Hauri D, Jaeger P. Pheochromocytomas: can malignant potential be predicted? Urology. 1999;53:679\u201383.","journal-title":"Urology"},{"key":"339_CR24","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.juro.2010.12.050","volume":"185","author":"F Feng","year":"2011","unstructured":"Feng F, Zhu Y, Wang X, Wu Y, Zhou W, Jin X, et al. Predictive factors for malignant pheochromocytoma: analysis of 136 patients. J Urol. 2011;185:1583\u20139.","journal-title":"J Urol"},{"key":"339_CR25","first-page":"1","volume":"0","author":"YY Cho","year":"2018","unstructured":"Cho YY, Kwak MK, Lee SE, Ahn SH, Kim H, Suh S, et al. A clinical prediction model to estimate the metastatic potential of pheochromocytoma\/paraganglioma: ASES score. Surgery. 2018;0:1\u20137.","journal-title":"Surgery"},{"key":"339_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/jso.23297","volume":"107","author":"P Goffredo","year":"2013","unstructured":"Goffredo P, Sosa JA, Roman SA. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades. J Surg Oncol. 2013;107:659\u201364.","journal-title":"J Surg Oncol"},{"key":"339_CR27","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.2967\/jnumed.108.058701","volume":"50","author":"GA Wiseman","year":"2009","unstructured":"Wiseman GA, Pacak K, O\u2019Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, et al. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med. 2009;50:1448\u201354.","journal-title":"J Nucl Med"},{"key":"339_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3803\/EnM.2017.32.2.152","volume":"32","author":"JWM Lenders","year":"2017","unstructured":"Lenders JWM, Eisenhofer G. Update on modern management of pheochromocytoma and paraganglioma. Endocrinol Metab. 2017;32:152","journal-title":"Endocrinol Metab"},{"key":"339_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1365-2796.2009.02111.x","volume":"266","author":"B Pasini","year":"2009","unstructured":"Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med. 2009;266:19\u201342.","journal-title":"J Intern Med"},{"key":"339_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1530\/EJE-14-0396","volume":"171","author":"EP Corssmit","year":"2014","unstructured":"Corssmit EP, Romijn JA. Management of endocrine disease: clinical management of paragangliomas. Eur J Endocrinol. 2014;171:231\u201343.","journal-title":"Eur J Endocrinol"},{"key":"339_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1385\/EP:16:1:023","volume":"16","author":"N Kimura","year":"2005","unstructured":"Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol. 2005;16:23\u201332.","journal-title":"Endocr Pathol"},{"key":"339_CR32","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.surg.2008.02.007","volume":"143","author":"VE Strong","year":"2008","unstructured":"Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y, et al. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle\/apoptosis gene expression analysis. Surgery. 2008;143:759\u201368.","journal-title":"Surgery"},{"key":"339_CR33","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1007\/s00268-010-0744-5","volume":"34","author":"A Agarwal","year":"2010","unstructured":"Agarwal A, Mehrotra PK, Jain M, Gupta SK, Mishra A, Chand G, et al. Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy? World J Surg. 2010;34:3022\u20138.","journal-title":"World J Surg"},{"key":"339_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","volume":"33","author":"D Wu","year":"2009","unstructured":"Wu D, Tischler AS, Lloyd RV, DeLellis RA, De Krijger R, Van Nederveen F, et al. Observer variation in the application of the pheochromocytoma of the adrenal gland scaled score. Am J Surg Pathol. 2009;33:599\u2013608.","journal-title":"Am J Surg Pathol"},{"key":"339_CR35","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1210\/jc.2017-00992","volume":"102","author":"O Hamidi","year":"2017","unstructured":"Hamidi O, Young WF, I\u00f1iguez-Ariza NM, Kittah NE, Gruber L, Bancos C, et al. Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years. J Clin Endocrinol Metab. 2017;102:3296\u2013305.","journal-title":"J Clin Endocrinol Metab"},{"key":"339_CR36","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/cen.13434","volume":"87","author":"O Hamidi","year":"2017","unstructured":"Hamidi O, Young WF, Gruber L, Smestad J, Yan Q, Ponce OJ, et al. Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: a systematic review and meta-analysis. Clin Endocrinol (Oxf). 2017;87:440\u201350.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"339_CR37","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.beem.2010.05.001","volume":"24","author":"G Opocher","year":"2010","unstructured":"Opocher G, Schiavi F. Genetics of pheochromocytomas and paragangliomas. Best Pract Res Clin Endocrinol Metab. 2010;24:943\u201356.","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0339-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0339-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:21:44Z","timestamp":1684617704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-019-0339-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["339"],"URL":"https:\/\/doi.org\/10.1038\/s41440-019-0339-y","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,4]]},"assertion":[{"value":"24 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}